Your browser doesn't support javascript.
loading
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
Shabto, Julie M; Martini, Dylan J; Liu, Yuan; Ravindranathan, Deepak; Brown, Jacqueline; Hitron, Emilie E; Russler, Greta A; Caulfield, Sarah; Kissick, Haydn; Alemozaffar, Mehrdad; Ogan, Kenneth; Harris, Wayne B; Master, Viraj A; Kucuk, Omer; Carthon, Bradley C; Bilen, Mehmet A.
Afiliación
  • Shabto JM; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Martini DJ; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Liu Y; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Brown J; Departments of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.
  • Hitron EE; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Russler GA; Department of Medicine, Emory University, Atlanta, GA, USA.
  • Caulfield S; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Kissick H; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Alemozaffar M; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Ogan K; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Harris WB; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Master VA; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
  • Kucuk O; Department of Pharmaceutical Services, Emory University School of Medicine, Atlanta, GA, USA.
  • Carthon BC; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Bilen MA; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Cancer Med ; 9(8): 2752-2760, 2020 04.
Article en En | MEDLINE | ID: mdl-32100417
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Urológicas / Medición de Riesgo / Inhibidores de Puntos de Control Inmunológico / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Urológicas / Medición de Riesgo / Inhibidores de Puntos de Control Inmunológico / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos